Scott L. Nyberg, M.D., Ph.D.

Location: Minnesota

Primary Appointment
Transplantation Surgery
Academic Rank
Professor of Surgery

Summary

The bioartificial liver is an important therapy developed to stabilize patients experiencing liver failure. The BAL functions outside of the patient's body, similar to hemodialysis in the treatment of kidney failure. However, the BAL is a 'hybrid' extracorporeal device in that it contains hepatocytes, most commonly of porcine or human origin, as a biological source of liver function. My research interests are focused on the development of a multidisciplinary bioartificial liver program to improve the treatment of liver failure and support the clinical liver transplant program. A multidisciplinary liver support team exists at Mayo and this team has participated in a phase III clinical trial of the HepatAssist BAL system. We have also developed our own BAL system based on spheroid technology and expect that these studies will lead to an improved device for clinical treatment of acute liver failure.

Recent publications

See my publications

Education

Fellowship – Solid Organ Transplantation
University of Minnesota

Chief Resident
University of Minnesota

Residency – General Surgery
University of Minnesota

Doctor of Philosophy – Biomedical Engineering
University of Minnesota

M.D.
The Johns Hopkins University School of Medicine

B.S. – Chemical Engineering
Massachusetts Institute of Technology

Areas of Research
Artificial liver and liver transplantation
Advanced liver diseases

Academic Affiliations
Biomedical Engineering Program

Appointments | Contact Us | Give to Mayo Clinic | Search

LEGAL RESTRICTIONS AND TERMS OF USE APPLICABLE TO THIS SITE